Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best affordable biotech stocks to invest in now. On September 12, UBS analyst Ashwani Verma maintained a Buy rating on Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) and set a price target of $50.00. Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Small-Cap Growth Stock to Buy Now? Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) reported its fiscal Q2 2025 results on August 5, with its WAKIX franchise continually delivering strong gr ...